본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Effect of High Dose Inhaled Glucocorticoids on Quality of Life in Patients with Moderate to Severe Asthma

Choi, Jae-Sung    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Jang, An-Soo    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Lee, June-Hyuk    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Park, Jong-Sook    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Park, Sung Woo    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Kim, Do-Jin    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.   ); Park, Choon-Sik    (Division of Allergy and Respiratory Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.  );
  • 초록

    Asthma is a chronic disorder that can place considerable restrictions on the physical, emotional, and social aspects of the lives of patients. Inhaled glucocorticoids (GCs) are the most effective controller therapy. The purpose of this study was to evaluate the effect of inhaled GCs on quality of life in patients with moderate to severe asthma. Patients completed the asthma quality of life questionnaire (AQLQ) and pulmonary function test at baseline and after 4 wks treatment of GCs. We enrolled 60 patients who had reversibility in FEV 1 after 200 μg of albuterol of 15% or more and/or positive methacholine provocation test, and initial FEV 1 % predicted less than 80%. All patients received inhaled GCs (fluticasone propionate 1,000 μg/day) for 4 wks. The score of AQLQ was significantly improved following inhaled GCs (overall 51.9±14.3 vs. 67.5±12.1, p 1 following inhaled GCs was diversely ranged from -21.0% to 126.8%. The improvement of score of AQLQ was not different between at baseline and after treatment of GCs according to asthma severity and GCs responsiveness. Quality of life was improved after inhaled GCs regardless of asthma severity and GCs responsiveness in patients with moderate to severe asthma.


  • 주제어

    Glucocorticoids .   Quality of Life .   Asthma.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기